🇺🇸 CYTK — Cytokinetics, Incorporated

Salud Compra fuerte
← Volver

Precio actual

62,31 USD

Máx. histórico

108,06

1030 días

Split 1:6 del 25/06/2013

Caída desde máximo

-42,34%

Rango 52 semanas

58,05 – 88,31

Variación hoy

+0,45%

Cierre anterior

62,03

Rango de hoy

62,05 – 64,37

Volumen hoy

1.699.286

Peor caída histórica

-97,06%

05/05/2004 → 10/10/2014

Recuperado en 3377 días

Volatilidad anualizada ⓘ

69,37%

Información
Nombre completo
Cytokinetics, Incorporated
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
673
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,39 USD (puede no estar actualizado)
Primera cotización
30/04/2004
Precio actualizado
hace 22 horas
Sobre la empresa

Cytokinetics, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators and muscle inhibitors as potential treatments for debilitating diseases in the United States. The company markets MYQORZO, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of symptomatic oHCM. It also develops Aficamten, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of HCM; and omecamtiv mecarbil, a potential treatment across the continuum of care in heart failure with severely reduced ejection fraction. In addition, the company is involved in developing and Ulacamten, a novel, selective, oral, and small molecule cardiac myosin inhibitor designed to reduce the hypercontractility associated with heart failure with preserved ejection fraction in Phase 1 clinical trials; and CK-089, a fast skeletal muscle troponin activator in Phase 1 clinical trials. Cytokinetics, Incorporated was incorporated in 1997 and is headquartered in South San Francisco, California.

Splits Registrados en el histórico de precios
Fecha Ratio
25/06/2013 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
03/04/2023 35,15 37,76 34,60 37,71 +7,16% 8,99% 1.556.100
31/03/2023 35,00 36,66 34,70 35,19 +2,86% 5,60% 3.036.600
30/03/2023 35,47 35,70 34,15 34,21 -2,95% 4,37% 838.200
29/03/2023 35,31 35,31 34,60 35,25 +0,77% 2,01% 591.200
28/03/2023 34,36 35,60 33,98 34,98 +1,30% 4,71% 803.700
27/03/2023 33,73 34,64 33,42 34,53 +3,51% 3,62% 539.800
24/03/2023 33,37 33,64 32,96 33,36 -0,80% 2,04% 720.700
23/03/2023 34,80 34,99 33,37 33,63 -2,15% 4,66% 815.100
22/03/2023 36,02 37,45 34,31 34,37 -5,00% 8,72% 804.900
21/03/2023 35,50 36,59 35,06 36,18 +2,78% 4,31% 1.414.500
20/03/2023 35,20 35,51 34,55 35,20 -0,37% 2,73% 841.100
17/03/2023 36,87 36,94 35,02 35,33 -4,67% 5,21% 2.429.100
16/03/2023 36,99 37,94 36,40 37,06 -0,56% 4,16% 1.146.100
15/03/2023 37,34 37,71 36,48 37,27 -1,30% 3,29% 767.700
14/03/2023 37,75 38,39 37,31 37,76 +1,31% 2,86% 895.200
13/03/2023 35,41 37,62 35,07 37,27 +4,69% 7,20% 1.499.600
10/03/2023 36,64 36,67 34,40 35,60 -3,42% 6,20% 1.812.000
09/03/2023 39,12 39,45 36,50 36,86 -6,07% 7,54% 1.190.500
08/03/2023 39,94 40,17 38,53 39,24 -2,17% 4,11% 861.100
07/03/2023 39,29 40,50 38,96 40,11 +2,50% 3,92% 1.156.500
06/03/2023 41,74 41,74 38,76 39,13 -6,72% 7,14% 1.990.700
03/03/2023 39,73 42,76 39,70 41,95 +5,93% 7,70% 1.066.000
02/03/2023 41,57 42,32 39,50 39,60 -8,14% 6,78% 1.692.700
01/03/2023 43,22 43,89 42,86 43,11 -0,58% 2,38% 977.300
28/02/2023 42,81 43,60 42,55 43,36 +0,88% 2,45% 1.110.300
27/02/2023 43,14 43,27 42,39 42,98 +0,40% 2,04% 445.800
24/02/2023 42,73 43,50 42,30 42,81 -0,65% 2,81% 743.100
23/02/2023 41,99 43,27 41,57 43,09 +3,23% 4,05% 676.300
22/02/2023 41,74 42,65 41,40 41,74 -0,71% 2,99% 873.700
21/02/2023 45,21 45,50 41,96 42,04 -8,03% 7,83% 1.114.200